|
HARBI1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.62389945513564E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.59210028178359E-10 |
| Normal-vs-Stage2 |
4.632700E-04 |
| Normal-vs-Stage3 |
5.18260000470505E-08 |
| Normal-vs-Stage4 |
1.380750E-03 |
| Stage1-vs-Stage2 |
1.869620E-01 |
| Stage1-vs-Stage3 |
9.200400E-01 |
| Stage1-vs-Stage4 |
2.012000E-01 |
| Stage2-vs-Stage3 |
2.670600E-01 |
| Stage2-vs-Stage4 |
9.418600E-01 |
| Stage3-vs-Stage4 |
2.630200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14260000350086E-08 |
| Normal-vs-AfricanAmerican |
5.82029999999234E-05 |
| Normal-vs-Asian |
2.208400E-01 |
| Caucasian-vs-AfricanAmerican |
5.865800E-01 |
| Caucasian-vs-Asian |
3.769800E-01 |
| AfricanAmerican-vs-Asian |
3.702800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.21149995485825E-10 |
| Normal-vs-Female |
1.10980000000982E-06 |
| Male-vs-Female |
1.216560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.06380000003603E-06 |
| Normal-vs-Age(41-60Yrs) |
4.27640000078E-08 |
| Normal-vs-Age(61-80Yrs) |
2.04609995613225E-09 |
| Normal-vs-Age(81-100Yrs) |
6.224500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.918400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.861400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.035400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.372200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.830400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.533000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.101100E-03 |
| Normal-vs-Grade 2 |
2.15020223848228E-11 |
| Normal-vs-Grade 3 |
1.76679999519536E-08 |
| Normal-vs-Grade 4 |
3.275900E-02 |
| Grade 1-vs-Grade 2 |
9.812800E-01 |
| Grade 1-vs-Grade 3 |
6.846800E-01 |
| Grade 1-vs-Grade 4 |
2.281400E-01 |
| Grade 2-vs-Grade 3 |
2.346000E-01 |
| Grade 2-vs-Grade 4 |
6.536400E-03 |
| Grade 3-vs-Grade 4 |
4.680200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.04325445452014E-12 |
| Normal-vs-ccB subtype |
2.80630000004667E-06 |
| ccA subtype-vs-ccB subtype |
1.521990E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.96739999636497E-08 |
| Normal-vs-N1 |
7.221900E-02 |
| N0-vs-N1 |
9.080400E-01 |
|
|
